Morningstar Assigns “AA-” Credit Rating to AstraZeneca plc (AZN)
AstraZeneca plc (NYSE:AZN) has received an “AA-” credit rating from analysts at Morningstar. The agency’s “AA-” rating suggests that the company is a very-low default risk. They also issued a negative credit outlook for the company and gave their stock a two star rating.
AZN has been the subject of a number of other recent research reports. Analysts at Panmure Gordon reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Friday, August 22nd. Separately, analysts at Deutsche Bank reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Friday, August 22nd. Finally, analysts at Beaufort Securities reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Friday, August 22nd. Four analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $57.00.
Shares of AstraZeneca plc (NYSE:AZN) opened at 76.01 on Tuesday. AstraZeneca plc has a 52-week low of $48.53 and a 52-week high of $82.68. The stock’s 50-day moving average is $72.64 and its 200-day moving average is $71.08. The company has a market cap of $96.001 billion and a P/E ratio of 46.31.
AstraZeneca plc (NYSE:AZN) last issued its quarterly earnings data on Thursday, July 31st. The company reported $1.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.09 by $0.21. The company had revenue of $6.45 billion for the quarter, compared to the consensus estimate of $6.24 billion. During the same quarter in the prior year, the company posted $1.20 earnings per share. The company’s quarterly revenue was up 3.6% on a year-over-year basis. Analysts expect that AstraZeneca plc will post $4.40 EPS for the current fiscal year.
The company also recently announced a semiannual dividend, which is scheduled for Monday, September 15th. Investors of record on Friday, August 15th will be paid a dividend of $0.90 per share. This represents a dividend yield of 2.48%. The ex-dividend date is Wednesday, August 13th.
AstraZeneca PLC (NYSE:AZN) is a global biopharmaceutical company.
To view more credit ratings from Morningstar, visit www.morningstar.com.
Receive News & Ratings for AstraZeneca plc (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.